ABSTRACT Changes in the sympathetic nerve system have been suggested as the pathophysiological mechanism underlying vibration white finger (VWF). The aim of the present study was to investigate if experimental support for such a mechanism could be found in VWF. Drugs with a known effect on sympathetic alpha receptors were administered into the finger skin by iontophoresis and their effects on blood flow in the same area evaluated using a laser Doppler technique. The effects of noradrenaline (stimulating alpha-I and alpha-2 receptors), phenylephrine (an alpha-I stimulator), and B-HT 933 (an alpha-2 stimulator) were studied in 12 patients with vibration white finger and 12 healthy controls. The reactions to noradrenaline and B-HT 933 were similar in both patients and controls, but the reaction of the patients to phenylephrine was significantly weaker than the controls. In additional experiments in six patients and six controls concentration effect curves to phenylephrine were derived. The curves for the patients were shifted to the right-that is, they reacted less strongly than the controls at all doses of the drug which induced an appreciable vasoconstriction. The results of this study are compatible with the hypothesis that the alpha-i receptor mediated responses are weakened in VWF. The predominance of alpha-2 receptors in the digital arteries has, on the basis of animal experiments, been suggested as a possible mechanism for Raynaud's phenomenon.
Constriction of the blood vessels is mediated through the sympathetic nerve fibres and many theories concerning the aetiology of Raynaud's phenomenon have implicated changes in the sympathetic nerve system. Raynaud himself proposed that the attacks in the primary disease were due to overactivity in sympathetic nerves.' Lewis assumed that the sympathetic nerve endings were affected with an increased sensitivity to cold2 whereas Magos and Okos suggested that the hypersensitivity to cold in vibration white finger (VWF) was caused by the accumulation of vasoactive substances in the walls of the vessels. 3 The postsynaptic alpha-adrenergic receptors that mediate vasoconstriction are of two subtypes, alpha-1 and alpha-2, characterised by a different reactivity to agonistic and antagonistic drugs.4 Thus alpha-lreceptors are preferentially stimulated by phenylephrine and blocked by prazosin whereas alpha-2-receptors are preferentially stimulated by B-HT 933 (azepexole) and blocked by yohimbine.S Some vessels seem to have adrenoceptors of only one subtype whereas others seem to have a mixed receptor population. 6 The existence of vascular alpha-l and alpha-2 Accepted 3 March 1986 receptors has been shown in vivo in man7 8 and postsynaptic alpha-receptors of both subtypes coexist in human digital vessels (JP Cooke et al, personal communication; unpublished results).
The study presented here was performed to determine whether or not alpha-adrenergic responses in the small finger skin vessels are altered in VWF and if any change in the response could be linked to a specific subtype of receptor.
Subjects and methods
Twelve patients with VWF were examined in the first set of experiments. They were in grade 2 or 3 according to the Taylor Pelmear symptom scale,9 and the disease had been verified by a pathological reaction to a cold provocation test.'0 Apart from VWF the patients were healthy and were taking no drugs. Twelve healthy men not exposed to vibrating tools were used as controls. Informed consent was obtained from all subjects, and the design of the study was approved by the local ethical committee.
A recently developed technique for the local application of vasoactive drugs into the skin with simultaneous measurement of the blood flow in the same skin area was used (LE Lindblad et al, unpublished
Is vibration white finger a primary sympathetic nerve injury? results). Substances with known effects on alpha-land alpha-2-receptors were introduced locally into the skin by an electric current (iontophoresis). Skin blood flow was registered with a laser Doppler technique (Periflux, Perimed, KB) before, during, and after the iontophoresis, and the result was registered on a strip chart recorder (GILA 401112, DLH Laumann) and a data logger (domestically produced). The signals from the data logger were analysed off line on a desk computer (HP 9856 B) with a sampling frequency of 20 Hz.
The laser Doppler technique gives only relative flow values and the change in flow has been calculated as the quotient between the flow after drug administration and the basal flow (B/A 100 in fig 1) . The basal flow was calculated as an average of the flow during the last four minutes before the start of the iontophoresis; the flow after drug administration was calculated from the last two minutes of the experiment (fig 1) .
The substances administered by iontophoresis were noradrenaline-HCl (Sigma Chemicals) 1 pmol/ml, phenylephrine (Sigma Chemicals) 1 umol/ml, and B-HT 933 (Boehringer Ingelheim) lOpmol/ml; all were dissolved in deionised water. In a pilot study on six healthy male volunteers the concentrations used were found to be the lowest that caused reduction of blood flow and visible blanching of the skin. In a second set of experiments phenylephrine concentrations from 0.01 pmol/ml to 100 pmol/ml were studied to derive concentration effect curves. The subjects were examined in a supine position. The probe holder was mounted on the dorsal side of the middle phalanx of the fourth finger. Skin temperature was registered and if less than 30°C the subject was warmed with a blanket before the start of the experiment until the finger temperature was above 30°C. To get a steady state circulation in the skin precautions were taken to prevent external disturbances during the experiments.
The first drug was introduced into the chamber and blood flow was registered for 15 minutes before the current (200 pA DC) was switched on. lontophoretic administration of the drug into the skin was performed for two minutes. Blood flow was monitored during and five minutes after the iontophoresis. The chamber was then moved to the third finger and the procedure was repeated with the second substance. The third substance was administered into the skin of the second finger. Blood flow was measured for five minutes before the new experiments. The drugs were administered in random order.
To verify the result obtained with phenylephrine in the study outlined above, a second set of experiments was designed. Six patients with vibration white finger and six healthy controls were examined in order to obtain concentration effect curves to phenylephrine. The chamber was mounted on the third finger, blood flow was registered for five minutes, and iontophoresis with phenylephrine 0,01 imol/ml was applied for two minutes. The current was switched off Fig 2 Analysis curve ofaphenylephrine concentration effect experiment. Effect of001 umol/ml is calculated as (B,/A). 100, effect of0 1 4umol/ml as (B2/A). 100, and so on. and the chamber was then immediately filled with phenylephrine 0,1 mol/ml without changing its position. Blood flow was registered again for five minutes before the current was switched on for two minutes. In the same way the experiment was continued with phenylephrine I ,umol/ml, 10 pmol/ml, and, in the patient group, 100 ,umol/ml.
The change in blood flow was calculated from the two minutes preceeding the first period of iontophoresis (A, fig 2) and two minutes before each of the following periods (B1-B4, fig 2) and the last two minutes of the experiment (B5) as the quotient between B and A (fig 2) . For 
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The alpha-2 agonist, B-HT 933, induced a vasoconstriction in all the controls. One of the patients had a slight increase in blood flow, but in the others the drug produced vasoconstriction. There was no significant difference between the reactions of patients and controls (fig 6) .
The result of the concentration effect experiments is shown in fig 7. The reactions of the patients were less pronounced than those of the controls and the differences between patients and controls were significant at 1 and 10 pmol/ml (p < 0 025 resp < 0 005).
Discussion
Vasoconstriction induced by alpha-I activity is reduced and that induced by alpha-2 activity is augmented by cooling. " In a vessel preparation with only alpha-2 receptors, obtained by blocking with an alpha-I antagonist, cooling increases the contractile responses to noradrenaline. " Thus in subjects preferentially having alpha-2 receptors in the digital vessels, cooling might lead to an exaggerated response. This has, on a theoretical basis, been suggested as a possible mechanism for Raynaud's phenomen. '2 In the present study patients with VWF reacted significantly weaker, on a group basis, than controls to an alpha-I stimulator, phenylephrine, whereas there were no significant differences in their reactions to noradrenaline or B-HT 933. The concentration effect curves for phenylephrine were shifted to the right in VWF patients compared with the controls. Thus both sets of experiments support the hypothesis that the patients with VWF have a reduced response to alpha-I receptor stimulation.
The weaker reaction to phenylephrine in VWF does not seem to depend on differences in skin permeability due, for example, to increased thickness of the skin, since the reactions to the other drugs were similar in the two groups. Alpha-I mediated vasoconstriction decreases on cooling, but there was no difference in finger temperature between patients and controls that could explain the results. The results, however, are compatible with a diminished alpha-I responsiveness in the small cutaneous blood vessels in the finger. A possible explanation could be a damage of alpha-I receptors due to vibration trauma. Two patients had a vasodilatation after iontophoretically administered phenylephrine and one after B-HT 933. This might be a chance phenomenon but was not seen in any of the controls. 
